[HTML][HTML] Eligibility of persons who inject drugs for treatment of hepatitis C virus infection
A Arain, G Robaeys - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
In this decade, an increase is expected in end-stage liver disease and hepatocellular
carcinoma, most commonly caused by hepatitis C virus (HCV) infection. Although people …
carcinoma, most commonly caused by hepatitis C virus (HCV) infection. Although people …
Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009
This study compared HIV sero-prevalence and risk behaviors between younger and older
injecting drug users (IDUs). IDUs aged≥ 18 years were interviewed for the 2009 National …
injecting drug users (IDUs). IDUs aged≥ 18 years were interviewed for the 2009 National …
WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs
Viral hepatitis B and C (HBV, HCV) disproportionately affect people who inject drugs (PWID)
across the world. To date there has been little global action focusing on prevention, care and …
across the world. To date there has been little global action focusing on prevention, care and …
[图书][B] Primary and secondary prevention of hepatitis C virus among rural Appalachian people who use drugs
DB Stephens - 2014 - search.proquest.com
Hepatitis C virus (HCV) remains a major cause of morbidity and mortality worldwide, with 3%
of the global population chronically infected. Clinical impacts in the United States are …
of the global population chronically infected. Clinical impacts in the United States are …